UCB (PK) 주식 가격. UCBJY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

93.50

매수가

93.02

매도가

95.09

거래량

9,796

93.22 일간 변동폭 95.46

44.26 52주 범위 100.66

market_cap

35.454B

전일 종가

98.535

개장가

95.46

최근 거래 시간

93.71

마지막 거래 시간

재정 규모

US$ 917,643

VWAP

93.6753

평균 볼륨(3m)

12,489

발행 주식

379,189,796

배당수익률

0.99%

주가수익률

203.40

주당순이익(EPS)

0.9

매출

4.87B

순이익

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

섹터

Pharmaceutical Preparations

산업

Chemicals & Allied Products

웹사이트

www.ucb.com

본부

Brussels, Brussels-capital Region, Bel

설립됨

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker UCBJY. The last closing price for UCB (PK) was US$98.54. Over the last year, UCB (PK) shares have traded in a share price range of US$ 44.26 to US$ 100.66.

UCB (PK) currently has 379,189,796 shares in issue. The market capitalisation of UCB (PK) is US$37.36 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 203.40.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-7.01	-6.97443040493	100.51	100.66	93.22	9834	98.44324394	DR
4	-2.25	-2.3498694517	95.75	100.66	93.22	8143	98.62864462	DR
12	-4.1	-4.20081967213	97.6	100.66	86.71	12489	96.74238634	DR
26	15.91	20.5052197448	77.59	100.66	74.55	16277	91.25328113	DR
52	48.78	109.078711986	44.72	100.66	44.26	17268	77.17582769	DR
156	43.4399	86.775495854	50.0601	100.66	32.82	20800	51.49115576	DR
260	48.04	105.675318962	45.46	100.66	32.45	20025	52.69239514	DR

UCBJY - Frequently Asked Questions (FAQ)

What is the current UCB (PK) share price?

The current share price of UCB (PK) is US$ 93.50

How many UCB (PK) shares are in issue?

UCB (PK) has 379,189,796 shares in issue

What is the market cap of UCB (PK)?

The market capitalisation of UCB (PK) is USD 37.36B

What is the 1 year trading range for UCB (PK) share price?

UCB (PK) has traded in the range of US$ 44.26 to US$ 100.66 during the past year

What is the PE ratio of UCB (PK)?

The price to earnings ratio of UCB (PK) is 203.4

What is the cash to sales ratio of UCB (PK)?

The cash to sales ratio of UCB (PK) is 14.34

What is the reporting currency for UCB (PK)?

UCB (PK) reports financial results in EUR

What is the latest annual turnover for UCB (PK)?

The latest annual turnover of UCB (PK) is EUR 4.87B

What is the latest annual profit for UCB (PK)?

The latest annual profit of UCB (PK) is EUR 343M

What is the registered address of UCB (PK)?

The registered address for UCB (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070

What is the UCB (PK) website address?

The website address for UCB (PK) is www.ucb.com

Which industry sector does UCB (PK) operate in?

UCB (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TMGIMarquie Group Inc (PK)	US$ 0.0002 (19,900.00%)	4.03M
SEANSAEAN Group Inc (PK)	US$ 1.87 (18,600.00%)	100
BRGOBergio International Inc (PK)	US$ 0.0001 (9,900.00%)	540k
GMPRGourmet Provisions International Corporation (PK)	US$ 0.0001 (9,900.00%)	35.31M
PLPLPlandai Biotechnology Inc (PK)	US$ 0.0001 (9,900.00%)	18.06M
STNXStartronix International Inc (CE)	US$ 0.000001 (-99.99%)	450
AWINAERWINS Technologies Inc (CE)	US$ 0.000001 (-99.97%)	2.03k
ISOLImage Software Inc (CE)	US$ 0.000001 (-99.91%)	59.2k
NBIONascent Biotech Inc (CE)	US$ 0.0002 (-99.55%)	8.7k
FHBCFernhill Beverage Inc (CE)	US$ 0.000001 (-99.24%)	10k
GTCHGBT Technologies Inc (PK)	US$ 0.0001 (0.00%)	349.77M
VTXBVortex Brands Company (PK)	US$ 0.0002 (0.00%)	297.52M
EMEDElectroMedical Technologies Inc (PK)	US$ 0.0002 (0.00%)	233.53M
PHILPHI Group Inc (PK)	US$ 0.0002 (-33.33%)	184.12M
HMBLHUMBL Inc (PK)	US$ 0.0009 (-5.26%)	179.2M